ENG
7364 visitors online
Darnitsa is in the rating of the companies implementing sustainable development strategies Darnitsa Pharmaceutical Company is in the Sustainable Development Rating-2021, which has been compiled by experts from the Dengi and Korrespondent magazines in partnership with the UN Global Compact Network in Ukraine. 41 0 Economics 
Darnitsa is the first Ukrainian company to join The Regulatory Affairs Professionals Society Darnitsa Pharmaceutical Company has become a member of the largest global organization of professionals involved with the regulation of healthcare and related products. 85 0 Economics 
Darnitsa Pharmaceutical company joins the Ukrainian Business & Trade Association Darnitsa Pharmaceutical company has become a member of the Ukrainian Business & Trade Association (UBTA). 149 0 Economics 
Microsoft cloud solutions increase Darnitsa’s adaptability to work in new conditions, - Shymkiv Darnitsa pharmaceutical company has implemented the cloud version of Office 365 and moved its key systems to the Microsoft Azure cloud platform to improve its business efficiency in the new environment. 56 0 Economics Darnitsa plans to reach a market cap of $1 billion, - Shymkiv Darnitsa Group intends to bring the group's market capitalization to $1 billion. Dmitriy Shymkiv, the Chairman of the Board of Darnitsa Group, informed about this in an interview with the Future Makers YouTube channel. 167 0 Ukrainian Politics Darnitsa reduces the time for equipment changeover operations by one third Darnitsa Pharmaceutical Company has moved to the second stage of implementation of projects to improve production processes. 35 0 Economics Supreme Court definitively confirmed Darnitsa’s proprietary interest in stocks of the Borshchahivskiy Chemical-Pharmaceutical plant The Supreme Court of Ukraine satisfied the cassation claim filed by the pharmaceutical company Darnitsa and cancelled the decision of the North Business Court of Appeal of Kyiv of August 25,2020 on Darnitsa’s purchase of PJSC SIC Borshchahivskiy CPP stocks during the process of state privatization in 2015. 1 379 0 Economics 
Darnitsa launches a post-COVID syndrome online project Darnitsa Pharmaceutical Company has created an online platform for collecting official information on the post-COVID syndrome – various side effects that can be experienced by those who have had the coronavirus infection. 67 0 Economics 
